Home Healthcare Market (Equipment, Service & Telehealth/Telemedicine) Current Trends, Opportunities & Global Forecasts to 2016

Introduction

Home healthcare includes support and care services and devices which are provided at the patient's home. These care services include respiratory therapy, home infusion therapy, rehabilitation services, telehealth, unskilled home care and other services.

The most significant healthcare trend witnessed recently is the shift of treatment from hospitals to home in order to gain a cost advantage and reduce hospital expenditure. The move from treatment to proactive monitoring is also opening up new opportunities for the home healthcare market. Patients prefer home healthcare over hospitals mainly for the convenience and cost-effectiveness it offers. Third party home healthcare is witnessing huge demand due to better treatment quality ensured by trained medical professionals. The home healthcare market is expected to grow at a CAGR of 7.7% from 2011 to 2016.

This market is witnessing tremendous growth due to the rise in the aging population not only in the developed regions of the world but also in the developing countries. Awareness about the convenience and cost effectiveness offered by these equipment and services is also increasing the demand for this market. Asia displays a high CAGR owing to the rapidly increasing aging population in countries such as India, China, and Japan. Americas also maintains a stable growth mainly due to the reimbursements offered for specific equipment and the health policies of Medicaid and Medicare. Portability, customization, and automation are the key factors that home healthcare market players use to differentiate their products and services.

The geographies studied include Americas (U.S., Canada, Brazil, Mexico, and Rest of Americas), Europe (Germany, France, U.K., Italy, Spain, Russia, and Rest of Europe), Asia (India, China, Japan, South Korea, and Rest of Asia), and ROW (Pacific region which includes Australia and New Zealand, Middle East and Africa). Among all the geographies mentioned above Americas commanded the largest share of 52.1% in the year 2011 of the Global Home Healthcare Market.

The scope of the report spans the home healthcare equipment market which comprises:

• Home healthcare equipment market
  • Home therapeutic equipment market
  • Respiratory care devices
  • Insulin delivery devices
  • Dialysis equipment
  • IV equipment
  • Hearing aids
  • Other therapeutic devices
• Home self-diagnostic monitoring equipment market
  • Diabetes care devices
  • Holter monitors
  • Fertility monitors
  • Heart rate meters
  • Apnea and sleep monitors
  • Patient monitors
  • Other monitoring devices
• Mobility assist and other equipment market
  • Wheelchairs and related devices
  • Walking assist devices
  • Medical furniture
• Home healthcare services market
  • Rehabilitation service providers
  • Unskilled home healthcare
  • Infusion therapy
  • Respiratory therapy
• Home telehealth market
  • Telehealth monitoring devices
  • Telehealth monitors
  • Medical peripheral devices
    • Blood glucose meters
    • Pulse oximeters
    • Weight Scale
    • Peak flow meters
    • Blood pressure monitors
    • Others
  • Telehealth monitoring services
  • Physician services
  • Nursing services
  • Managed Equipment Services

Each section of the Home Healthcare Market research report offers market data for the various market segments and geographies. It also provides market trends with respect to drivers, restraints, and opportunities.

Founded in 2001, M&M is a full service market research company and consulting firm that produces 240 high-level, strategically analyzed, full-length reports a year, tracking more than 10 industries. M&M plans to launch industry-wise and country-wise market tracker reports for all the verticals we track. This intelligence database comprising of about 60,000 reports a year, will form one of the world's largest business intelligence resources worldwide. M&M has effectively used technology to automate the management of large and complex market data tables and forecasts.

Table of Contents

1. INTRODUCTION

• 1.1. KEY TAKE-AWAYS
• 1.2. REPORT DESCRIPTION
• 1.3. MARKETS COVERED
• 1.4. STAKEHOLDERS
• 1.5. RESEARCH METHODOLOGY
  • 1.5.1. MARKET SIZE
  • 1.5.2. KEY DATA POINTS FROM SECONDARY SOURCES
  • 1.5.3. KEY DATA POINTS FROM PRIMARY SOURCES
  • 1.5.4. ASSUMPTIONS

2. EXECUTIVE SUMMARY

3. MARKET OVERVIEW

• 3.1. INTRODUCTION
• 3.2. NEED FOR HOME HEALTHCARE
• 3.3. MARKET SEGMENTATION
• 3.4. EVOLUTION
• 3.5. MARKET DYNAMICS
  • 3.5.1. DRIVERS
    • 3.5.1.1. Aging population is a key factor contributing to the adoption of healthcare at home
    • 3.5.1.2. Rising healthcare costs create a need for more affordable treatment options
    • 3.5.1.3. Rising incidence of chronic diseases directly impacts the demand for therapy and monitoring at home
    • 3.5.1.4. Technological advances make durable medical equipment a feasible option for use at-home
    • 3.5.1.5. Rise in the number of home healthcare personnel
  • 3.5.2. RESTRAINTS
    • 3.5.2.1. Unique risks to the personal safety and health of the healthcare workers
    • 3.5.2.2. Change in reimbursement policies
    • 3.5.2.3. Limited coverage for home care devices
    • 3.5.2.4. Regulatory obstacles for newer generation of home healthcare products
  • 3.5.3. OPPORTUNITIES
    • 3.5.3.1. Strategic aligning offers cost efficiency
    • 3.5.3.2. Telehealth improves patient monitoring
  • 3.5.3.3. Home healthcare market shifting focus to developing regions
• 3.6. MARKET SHARE ANALYSIS

4. HOME HEALTHCARE EQUIPMENT

• 4.1. INTRODUCTION
• 4.2. DRIVERS
  • 4.2.1. COST & CONVENIENCE
  • 4.2.2. INCREASING AWARENESS OF SELF-DIAGNOSTIC METHODS
  • 4.2.3. RISING PREVALENCE OF DISEASES & AGING POPULATION
• 4.3. RESTRAINTS
  • 4.3.1. RESTRAINED TECHNOLOGY ADOPTION
  • 4.3.2. LACK OF DIRECT REIMBURSEMENT POLICIES
  • 4.3.3. FAST CHANGING TECHNOLOGIES
• 4.4. SELF DIAGNOSTICS / MONITORING EQUIPMENT
  • 4.4.1. MARKET DYNAMICS
    • 4.4.1.1. Increasing prevalence of lifestyle diseases
    • 4.4.1.2. Lack of reimbursement in developing nations
    • 4.4.1.3. Self diagnostic/monitoring devices dominate the equipment market
  • 4.4.2. HOME DIABETES CARE DEVICES
    • 4.4.2.1. Blood glucose meters
    • 4.4.2.2. Blood glucose test strips
  • 4.4.3. HOME HOLTER MONITORS
  • 4.4.4. HOME PREGNANCY/FERTILITY TESTS
  • 4.4.5. HEART RATE METERS
  • 4.4.6. HOME - APNEA & SLEEP MONITORS
  • 4.4.7. HOME PATIENT MONITORS
  • 4.4.8. OTHER HOME PATIENT MONITORS
• 4.5. HOME HEALTHCARE THERAPEUTIC EQUIPMENT
  • 4.5.1. HOME RESPIRATORY THERAPY EQUIPMENT
    • 4.5.1.1. Oxygen delivery systems
    • 4.5.1.2. Continuous positive airway pressure products (CPAP)
    • 4.5.1.3. Medical nebulizer kits and devices
    • 4.5.1.4. Medical ventilators and accessories
  • 4.5.2. HOME IV EQUIPMENT
  • 4.5.3. HOME INSULIN DELIVERY DEVICES
  • 4.5.4. HOME DIALYSIS EQUIPMENT
  • 4.5.5. HEARING AIDS MARKET
  • 4.5.6. OTHER HOME THERAPEUTIC EQUIPMENT
• 4.6. MOBILITY ASSIST & OTHER EQUIPMENT
  • 4.6.1. WHEELCHAIRS AND RELATED DEVICES
  • 4.6.2. WALKING ASSIST DEVICES
  • 4.6.3. HOME MEDICAL FURNITURE

5. HOME HEALTHCARE SERVICES MARKET

• 5.1. INTRODUCTION
• 5.2. IMPACT ANALYSIS
• 5.3. OPPORTUNITIES
• 5.4. REHABILITATION SERVICE PROVIDERS
  • 5.4.1. PHYSICAL THERAPY
  • 5.4.2. OCCUPATIONAL THERAPY
  • 5.4.3. SPEECH THERAPY
• 5.5. UNSKILLED HOME HEALTHCARE
• 5.6. INFUSION THERAPY
• 5.7. RESPIRATORY THERAPY SERVICES

6. GLOBAL HOME TELEHEALTH MARKET

• 6.1. INTRODUCTION
• 6.2. MARKET DYNAMICS
  • 6.2.1. RISING HEALTHCARE EXPENDITURE TO FUEL THE GROWTH OF THE HOME TELEHEALTH MARKET
  • 6.2.2. INADEQUATE SUPPLY OF HEALTHCARE PROFESSIONALS DEMANDS CHANGE IN HEALTHCARE DELIVERY SYSTEM
  • 6.2.3. INADEQUATE HEALTHCARE INFRASTRUCTURE IN DEVELOPING ECONOMIES TO BE AN IMPETUS FOR GROWTH OF THE HOME TELEHEALTH MARKET
  • 6.2.4. HEALTHCARE REFORMS IN RUSSIA TO CREATE MAJOR GROWTH OPPORTUNITIES FOR HOME TELEHEALTH MARKET IN EUROPE
  • 6.2.5. TELEHEALTH SERVICE MARKET TO REGISTER THE HIGHEST GROWTH IN THE COMING YEARS
• 6.3. HOME TELEHEALTH MONITORING DEVICES
• 6.4. HOME TELEHEALTH SERVICES

7. GEOGRAPHICAL ANALYSIS

• 7.1. INTRODUCTION
• 7.2. AMERICAS
• 7.3. EUROPE
• 7.4. ASIA
• 7.5. ROW

8. COMPETITIVE LANDSCAPE

• 8.1. INTRODUCTION
  • 8.1.1. EQUIPMENT
  • 8.1.2. SERVICES
  • 8.1.3. TECHNOLOGY

9. COMPANY PROFILES

• 9.1. ABBOTT LABORATORIES
  • 9.1.1. OVERVIEW
  • 9.1.2. FINANCIALS
  • 9.1.3. PRODUCTS & SERVICES
  • 9.1.4. STRATEGY
  • 9.1.5. DEVELOPMENTS
• 9.2. AIR LIQUIDE S.A.
  • 9.2.1. OVERVIEW
  • 9.2.2. FINANCIALS
  • 9.2.3. PRODUCTS & SERVICES
  • 9.2.4. STRATEGY
  • 9.2.5. DEVELOPMENTS
• 9.3. AMEDISYS INC
  • 9.3.1. OVERVIEW
  • 9.3.2. FINANCIALS
  • 9.3.3. PRODUCTS & SERVICES
  • 9.3.4. STRATEGY
  • 9.3.5. DEVELOPMENTS
• 9.4. AMERICAN HOMEPATIENT INC.
  • 9.4.1. OVERVIEW
  • 9.4.2. FINANCIALS
  • 9.4.3. PRODUCTS & SERVICES
  • 9.4.4. STRATEGY
  • 9.4.5. DEVELOPMENT
• 9.5. APRIA HEALTHCARE GROUP INC.
  • 9.5.1. OVERVIEW
  • 9.5.2. FINANCIALS
  • 9.5.3. PRODUCTS & SERVICES
  • 9.5.4. STRATEGY
  • 9.5.5. DEVELOPMENT
• 9.6. BAXTER INTERNATIONAL INC.
  • 9.6.1. OVERVIEW
  • 9.6.2. FINANCIALS
  • 9.6.3. PRODUCTS & SERVICES
  • 9.6.4. STRATEGY
  • 9.6.5. DEVELOPMENTS
• 9.7. BAYER AG
  • 9.7.1. OVERVIEW
  • 9.7.2. FINANCIALS
  • 9.7.3. PRODUCTS & SERVICES
  • 9.7.4. STRATEGY
  • 9.7.5. DEVELOPMENTS
• 9.8. B. BRAUN MELSUNGEN AG
  • 9.8.1. OVERVIEW
  • 9.8.2. FINANCIALS
  • 9.8.3. PRODUCTS & SERVICES
  • 9.8.4. STRATEGY
  • 9.8.5. DEVELOPMENTS
• 9.9. CAREFUSION CORPORATION
  • 9.9.1. OVERVIEW
  • 9.9.2. FINANCIALS
  • 9.9.3. PRODUCTS & SERVICES
  • 9.9.4. STRATEGY
  • 9.9.5. DEVELOPMENTS
• 9.10. COLOPLAST A/S
  • 9.10.1. OVERVIEW
  • 9.10.2. FINANCIALS
  • 9.10.3. PRODUCTS & SERVICES
  • 9.10.4. STRATEGY
  • 9.10.5. DEVELOPMENTS
• 9.11. CONVATEC INC
  • 9.11.1. OVERVIEW
  • 9.11.2. FINANCIALS
  • 9.11.3. PRODUCTS & SERVICES
  • 9.11.4. STRATEGY
  • 9.11.5. DEVELOPMENTS
• 9.12. COVIDIEN PLC
  • 9.12.1. OVERVIEW
  • 9.12.2. FINANCIALS
  • 9.12.3. PRODUCTS & SERVICES
  • 9.12.4. STRATEGY
  • 9.12.5. DEVELOPMENTS
• 9.13. C.R. BARD INC.
  • 9.13.1. OVERVIEW
  • 9.13.2. FINANCIALS
  • 9.13.3. PRODUCTS & SERVICES
  • 9.13.4. STRATEGY
• 9.14. ELI LILLY AND COMPANY
  • 9.14.1. OVERVIEW
  • 9.14.2. FINANCIALS
  • 9.14.3. PRODUCTS & SERVICES
  • 9.14.4. STRATEGY
  • 9.14.5. DEVELOPMENTS
• 9.15. FRESENIUS SE & CO. KGAA
  • 9.15.1. OVERVIEW
  • 9.15.2. FINANCIALS
  • 9.15.3 PRODUCTS & SERVICES
  • 9.15.4. STRATEGY
  • 9.15.5. DEVELOPMENTS
• 9.16. GE HEALTHCARE
  • 9.16.1. OVERVIEW
  • 9.16.2. FINANCIALS
  • 9.16.3. PRODUCTS & SERVICES
  • 9.16.4. STRATEGY
  • 9.16.5. DEVELOPMENTS
• 9.17. GENTIVA HEALTH SERVICES INC.
  • 9.17.1. OVERVIEW:
  • 9.17.2. FINANCIALS
  • 9.17.3. PRODUCTS & SERVICES
  • 9.17.4. STRATEGY
  • 9.17.5. DEVELOPMENTS:
• 9.18. PHILIPS HEALTHCARE
  • 9.18.1. OVERVIEW
  • 9.18.2. FINANCIALS
  • 9.18.3. PRODUCTS & SERVICES
  • 9.18.4. STRATEGY
  • 9.18.5. DEVELOPMENTS
• 9.19. INVACARE CORPORATION
  • 9.19.1. OVERVIEW
  • 9.19.2. FINANCIALS
  • 9.19.3. PRODUCTS & SERVICES
  • 9.19.4. STRATEGY
• 9.20. JOHNSON AND JOHNSON
  • 9.20.1. OVERVIEW
  • 9.20.2. FINANCIALS
  • 9.20.3. PRODUCTS & SERVICES
  • 9.20.4. STRATEGY
  • 9.20.5. DEVELOPMENTS
• 9.21. LINCARE HOLDINGS INC.
  • 9.21.1. OVERVIEW:
  • 9.21.2. FINANCIALS
  • 9.21.3. PRODUCTS & SERVICES
  • 9.21.4. STRATEGY
  • 9.21.5. DEVELOPMENT
• 9.22. MEDTRONIC INC.
  • 9.22.1. OVERVIEW
  • 9.22.2. FINANCIALS
  • 9.22.3. PRODUCTS & SERVICES
  • 9.22.4. STRATEGY
  • 9.22.5. DEVELOPMENTS
• 9.23. NOVO NORDISK
  • 9.23.1. OVERVIEW
  • 9.23.2. FINANCIALS
  • 9.23.3. PRODUCTS & SERVICES
  • 9.23.4. STRATEGY
  • 9.23.5. DEVELOPMENTS
• 9.24. OMRON HEALTHCARE INC.
  • 9.24.1. OVERVIEW
  • 9.24.2. FINANCIALS
  • 9.24.3. PRODUCTS & SERVICES
  • 9.24.4. STRATEGY
  • 9.24.5. DEVELOPMENTS
• 9.25. ROBERT BOSCH GMBH
  • 9.25.1. OVERVIEW
  • 9.25.2. FINANCIALS
  • 9.25.3. PRODUCTS & SERVICES
  • 9.25.4. STRATEGY
  • 9.25.5. DEVELOPMENTS
• 9.26. ROCHE DIAGNOSTICS LIMITED
  • 9.26.1. OVERVIEW
  • 9.26.2. FINANCIALS
  • 9.26.3. PRODUCTS & SERVICES
  • 9.26.4. STRATEGY
  • 9.26.5. DEVELOPMENTS
• 9.27. ROTECH HEALTHCARE INC.
  • 9.27.1. OVERVIEW:
  • 9.27.2. FINANCIALS:
  • 9.27.3. PRODUCTS & SERVICES
  • 9.27.4. STRATEGY
  • 9.27.5. DEVELOPMENTS:
• 9.28. SIEMENS HEALTHCARE
  • 9.28.1. OVERVIEW
  • 9.28.2. FINANCIALS
  • 9.28.3. PRODUCTS & SERVICES
• 9.29. SUNRISE MEDICAL INC.
  • 9.29.1. OVERVIEW
  • 9.29.2. FINANCIALS
  • 9.29.3. PRODUCTS & SERVICES
  • 9.29.4. STRATEGY
  • 9.29.5. DEVELOPMENTS
• 9.30. TELEFLEX INCORPORATED
  • 9.30.1. OVERVIEW
  • 9.30.2. FINANCIALS
  • 9.30.3. PRODUCTS & SERVICES
  • 9.30.4. STRATEGY
  • 9.30.5. DEVELOPMENTS
• 9.31. TERUMO CORPORATION
  • 9.31.1. OVERVIEW
  • 9.31.2. FINANCIALS
  • 9.31.3. PRODUCTS & SERVICES
  • 9.31.4. STRATEGY
  • 9.31.5. DEVELOPMENTS

• TABLE 1: GLOBAL HOME HEALTHCARE MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
• TABLE 2: GLOBAL HOME HEALTHCARE EQUIPMENT MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
• TABLE 3: HOME HEALTHCARE EQUIPMENT MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 4: GLOBAL HOME MONITORING EQUIPMENT MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
• TABLE 5: HOME MONITORING EQUIPMENT MARKET REVENUE, BY GEOGRAPHY,2009 - 2016 ($MILLION)
• TABLE 6: GLOBAL HOME DIABETES CARE DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
• TABLE 7: HOME DIABETES CARE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 8: HOME BLOOD GLUCOSE METERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 9: GLOBAL BLOOD GLUCOSE METERS MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
• TABLE 10: HOME HOLTER MONITORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 11: HOME PREGNANCY/FERTILITY TEST MARKET REVENUE, BY GEOGRAPHY,2009 - 2016 ($MILLION)
• TABLE 12: HEART RATE METERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 13: HOME APNEA & SLEEP MONITORS MARKET REVENUE, BY GEOGRAPHY,2009 - 2016 ($MILLION)
• TABLE 14: HOME PATIENT MONITORS MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
• TABLE 15: HOME PATIENT MONITORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 16: GLOBAL HOME BLOOD PRESSURE MONITORS MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
• TABLE 17: HOME BLOOD PRESSURE MONITORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 18: GLOBAL HOME DIGITAL BLOOD PRESSURE MONITORS MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
• TABLE 19: OTHER HOME MONITORING EQUIPMENT MARKET REVENUE, BY GEOGRAPHY 2009 - 2016 ($MILLION)
• TABLE 20: GLOBAL HOME HEALTHCARE THERAPEUTIC EQUIPMENT MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
• TABLE 21: HOME HEALTHCARE THERAPEUTIC EQUIPMENT MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 22: GLOBAL HOME RESPIRATORY THERAPY EQUIPMENT MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
• TABLE 23: HOME RESPIRATORY THERAPY EQUIPMENT MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 24: HOME OXYGEN DELIVERY SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 25: HOME CPAP MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 26: HOME MEDICAL NEBULIZER KITS & DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 27: HOME MEDICAL VENTILATORS AND ACCESSORIES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 28: HOME IV (INTRAVENOUS) EQUIPMENT MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 29: HOME INSULIN DELIVERY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 30: GLOBAL INSULIN DELIVERY DEVICES MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
• TABLE 31: HOME DIALYSIS EQUIPMENT MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 32: HOME DIALYSIS EQUIPMENT MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
• TABLE 33: HEARING AIDS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 34: OTHER HOME THERAPEUTIC EQUIPMENT MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
• TABLE 35: OTHER HOME THERAPEUTIC EQUIPMENT MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 36: GLOBAL MOBILITY ASSIST AND OTHER EQUIPMENT MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
• TABLE 37: MOBILITY ASSIST AND OTHER EQUIPMENT MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 38: HOME WHEELCHAIR AND RELATED DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 39: HOME WALKING ASSIST DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 40: HOME MEDICAL FURNITURE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 41: GLOBAL HOME HEALTHCARE SERVICES MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
• TABLE 42: HOME HEALTHCARE SERVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 43: REHABILITATION SERVICE PROVIDERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016, ($MILLION)
• TABLE 44: UNSKILLED SERVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 45: INFUSION THERAPY SERVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 46: RESPIRATORY THERAPY SERVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 47: GLOBAL HOME TELEHEALTH MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($THOUSANDS)
• TABLE 48: HOME TELEHEALTH MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($THOUSANDS)
• TABLE 49: GLOBAL HOME TELEHEALTH MONITORING DEVICES MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($THOUSANDS)
• TABLE 50: HOME TELEHEALTH MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($THOUSANDS)
• TABLE 51: GLOBAL HOME TELEHEALTH SERVICES MARKET REVENUE, BY SEGMENTS, 2009 - 2016, ($THOUSANDS)
• TABLE 52: HOME TELEHEALTH SERVICES MARKET REVENUE, BY GEOGRAPHY,2009-2016 ($THOUSANDS)
• TABLE 53: HOME HEALTHCARE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
• TABLE 54: AMERICAS: HOME HEALTHCARE MARKET REVENUE, BY SEGMENTS, 2009 - 2016, ($MILLION)
• TABLE 55: AMERICAS: HOME HEALTHCARE MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 56: AMERICAS: HOME HEALTHCARE SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 57: AMERICAS: HOME HEALTHCARE REHABILITATION SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 58: AMERICAS: HOME HEALTHCARE UNSKILLED SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 59: AMERICAS: HOME HEALTHCARE INFUSION SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 60: AMERICAS: HOME HEALTHCARE RESPIRATORY SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 61: AMERICAS: HOME HEALTHCARE EQUIPMENT MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 62: AMERICAS: HOME HEALTHCARE MONITORING DEVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 63: AMERICAS: HOME HEALTHCARE THERAPEUTIC DEVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 64: AMERICAS: HOME HEALTHCARE MOBILITY ASSIST DEVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 65: EUROPE: HOME HEALTHCARE MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
• TABLE 66: EUROPE: HOME HEALTHCARE MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 67: EUROPE: HOME HEALTHCARE SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 68: EUROPE: HOME HEALTHCARE REHABILITATION SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 69: EUROPE: HOME HEALTHCARE UNSKILLED SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 70: EUROPE: HOME HEALTHCARE INFUSION SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 71: EUROPE: HOME HEALTHCARE RESPIRATORY SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 72: EUROPE: HOME HEALTHCARE EQUIPMENT MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 73: EUROPE: HOME HEALTHCARE MONITORING DEVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 74: EUROPE: HOME HEALTHCARE THERAPEUTIC DEVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 75: EUROPE: HOME HEALTHCARE MOBILITY ASSIST DEVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 76: ASIA: HOME HEALTHCARE MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)
• TABLE 77: ASIA: HOME HEALTHCARE MARKET REVENUE, BY COUNTRY, 2009 - 2016, ($MILLION)
• TABLE 78: ASIA: HOME HEALTHCARE SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 79: ASIA: HOME HEALTHCARE REHABILITATION SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 80: ASIA: HOME HEALTHCARE UNSKILLED SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 81: ASIA: HOME HEALTHCARE INFUSION SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 82: ASIA: HOME HEALTHCARE RESPIRATORY SERVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 83: ASIA: HOME HEALTHCARE EQUIPMENT MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 84: ASIA: HOME HEALTHCARE MONITORING DEVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 85: ASIA: HOME HEALTHCARE THERAPEUTIC DEVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 86: ASIA: HOME HEALTHCARE MOBILITY ASSIST DEVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 87: ROW: HOME HEALTHCARE MARKET REVENUE, BY SEGMENTS, 2009 - 2016, ($MILLION)
• TABLE 88: ROW: HOME HEALTHCARE MARKET REVENUE, BY REGION, 2009 - 2016, ($MILLION)
• TABLE 89: ROW: HOME HEALTHCARE SERVICES MARKET REVENUE, BY REGION, 2009 - 2016 ($MILLION)
• TABLE 90: ROW: HOME HEALTHCARE REHABILITATION SERVICES MARKET REVENUE, BY REGION, 2009 - 2016 ($MILLION)
• TABLE 91: ROW: HOME HEALTHCARE UNSKILLED SERVICES MARKET REVENUE, BY REGION, 2009 - 2016 ($MILLION)
• TABLE 92: ROW: HOME HEALTHCARE INFUSION SERVICES MARKET REVENUE, BY REGION, 2009 - 2016 ($MILLION)
• TABLE 93: ROW: HOME HEALTHCARE RESPIRATORY SERVICES MARKET REVENUE, BY REGION, 2009 - 2016 ($MILLION)
• TABLE 94: ROW: HOME HEALTHCARE EQUIPMENT MARKET REVENUE, BY REGION, 2009 - 2016 ($MILLION)
• TABLE 95: ROW: HOME HEALTHCARE MONITORING DEVICES MARKET REVENUE, BY REGION, 2009 - 2016 ($MILLION)
• TABLE 96: ROW: HOME HEALTHCARE THERAPEUTIC DEVICES MARKET REVENUE, BY REGION, 2009 - 2016 ($MILLION)
• TABLE 97: ROW: HOME HEALTHCARE MOBILITY ASSIST DEVICES MARKET REVENUE, BY COUNTRY, 2009 - 2016 ($MILLION)
• TABLE 98: EQUIPMENT: MERGER & ACQUISITIONS, 2009 - 2011
• TABLE 99: EQUIPMENT: NEW PRODUCT DEVELOPMENTS, 2009 - 2012
• TABLE 100: EQUIPMENT: AGREEMENTS & COLLABORATIONS, 2009 - 2012
• TABLE 101: SERVICES: MERGERS & ACQUISITIONS, 2009 - 2012
• TABLE 102: SERVICES: AGREEMENTS & COLLABORATIONS, 2009 - 2012
• TABLE 103: TECHNOLOGY: AGREEMENTS & COLLABORATIONS, 2009 - 2012
• TABLE 104: TECHNOLOGY: NEW PRODUCT DEVELOPMENTS, 2009 - 2012
• TABLE 105: ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 106: ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 107: ABBOTT LABORATORIES: GEOGRAPHIC REVENUES, 2009 - 2011 ($MILLION)
• TABLE 108: AIR LIQUIDE S.A.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 109: AIR LIQUIDE S.A.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 110: AMEDISYS INC: TOTAL REVENUE, 2009 - 2011 ($MILLION)
• TABLE 111: AMEDISYS INC: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 112: APRIA HEALTHCARE GROUP INC: TOTAL REVENUE, 2009 - 2010 ($MILLION)
• TABLE 113: APRIA HEALTHCARE GROUP INC: TOTAL REVENUE, BY SEGMENTS, ($MILLION)
• TABLE 114: BAXTER INTERNATIONAL INC: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 115: BAXTER INTERNATIONAL INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 116: BAXTER INTERNATIONAL INC: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 117: BAYER: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 118: BAYER: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 119: BAYER: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 120: B. BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 121: B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 122: B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2010 ($MILLION)
• TABLE 123: CAREFUSION: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 124: CAREFUSION: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 125: CAREFUSION: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 126: COLOPLAST A/S: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 127: COLOPLAST A/S: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 128: COLOPLAST A/S: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 129: CONVATEC INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2010 ($MILLION)
• TABLE 130: CONVATEC INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2010 ($MILLION)
• TABLE 131: CONVATEC INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2010 ($MILLION)
• TABLE 132: COVIDIEN PLC: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 133: COVIDIEN PLC: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 134: COVIDIEN PLC: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 135: COVIDIEN PLC: PRODUCTS, BY CATEGORY
• TABLE 136: C.R. BARD INC: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 137: C.R. BARD INC: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 138: C.R. BARD INC: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 139: ELI LILLY AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 140: ELI LILLY AND COMPANY: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 141: ELI LILLY AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, 2009 -2011 ($MILLION)
• TABLE 142: FRESENIUS SE & CO KGAA: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 143: FRESENIUS SE & CO KGAA: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 144: FRESENIUS SE & CO KGAA: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 145: GE HEALTHCARE: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 146: GE HEALTHCARE: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 147: GE HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 148: GENTIVA HEALTH SERVICES INC: TOTAL REVENUE, 2009 - 2011 ($MILLION)
• TABLE 149: GENTIVA HEALTH SERVICES INC: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 150: PHILIPS HEALTHCARE: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 151: PHILIPS HEALTHCARE: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 152: PHILIPS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, 2009 -2011($MILLION)
• TABLE 153: INVACARE CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 154: INVACARE CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 155: JOHNSON AND JOHNSON: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 156: JOHNSON AND JOHNSON: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 157: JOHNSON AND JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 158: LINCARE HOLDINGS INC: TOTAL REVENUE, 2009 - 2011 ($MILLION)
• TABLE 159: LINCARE HOLDINGS INC: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 160: MEDTRONIC INC: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 161: MEDTRONIC, INC: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 162: MEDTRONIC INC: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 163: PHILIPS HEALTHCARE: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 164: PHILIPS HEALTHCARE: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 165: PHILIPS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 166: OMRON: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 167: OMRON: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 168: OMRON: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 169: ROBERT BOSCH GMBH: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($MILLION)
• TABLE 170: ROBERT BOSCH GMBH: TOTAL REVENUE, BY SEGMENTS, 2009 - 2010 ($MILLION)
• TABLE 171: ROBERT BOSCH GMBH: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2010 ($MILLION)
• TABLE 172: ROCHE: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 173: ROCHE: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 174: ROCHE: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 175: ROTECH HEALTHCARE INC: TOTAL REVENUE, 2009 - 2011 ($MILLION)
• TABLE 176: SIEMENS HEALTHCARE: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 177: SIEMENS HEALTHCARE: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 178: SIEMENS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 179: TELEFLEX INCORPORATED: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 180: TELEFLEX INCORPORATED: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 181: TELEFLEX INCORPORATED: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
• TABLE 182: TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
• TABLE 183: TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
• TABLE 184: TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)

• FIGURE 1: HOME HEALTHCARE MARKET SEGMENTATION
• FIGURE 2: HOME HEALTHCARE MARKET, 2011 - 2016
• FIGURE 3: AGING POPULATION IS THE KEY DRIVER
• FIGURE 4: TECHNOLOGICAL ADVANCEMENTS IN THE HOME HEALTHCARE MARKET
• FIGURE 5: MARKET SHARE ANALYSIS OF HOME HEALTHCARE SERVICES, BY COMPANY, 2011
• FIGURE 6: HOME MONITORING DEVICES, BY MARKET SHARE, 2011 VS 2016
• FIGURE 7: IMPACT ANALYSIS
• FIGURE 8: HOME TELEHEALTH MARKET SEGMENTATION
• FIGURE 9: EQUIPMENT: KEY GROWTH STRATEGIES (JANUARY 2009 - FEBRUARY 2012)
• FIGURE 10: SERVICES: KEY GROWTH STRATEGIES (JANUARY 2009 - FEBRUARY 2012) 201
• FIGURE 11: TECHNOLOGY: KEY GROWTH STRATEGIES (JANUARY 2009 - FEBRUARY 2012)

Home Healthcare Market (Equipment, Service & Telehealth/Telemedicine) Current Trends, Opportunities & Global Forecasts to 2016 published by Markets and Markets in April 9, 2012. This report consists of 399 Pages and the price starts from US $ 4650.

The contents of this page may be different from the latest version. Please contact us for details.